These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9393735

  • 1. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Huebner K, Croce CM, Pierotti MA.
    Cancer Res; 1997 Dec 01; 57(23):5207-12. PubMed ID: 9393735
    [Abstract] [Full Text] [Related]

  • 2. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S.
    Cancer Res; 1998 Nov 15; 58(22):5032-7. PubMed ID: 9823304
    [Abstract] [Full Text] [Related]

  • 3. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 4. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines.
    Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T.
    Cancer Res; 1996 Dec 15; 56(24):5579-82. PubMed ID: 8971157
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y, Nakajima T, Kohno T, Saito R, Yamaguchi N, Yokota J.
    Cancer Res; 1998 Dec 01; 58(23):5478-83. PubMed ID: 9850082
    [Abstract] [Full Text] [Related]

  • 7. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C.
    J Pathol; 2001 Jan 15; 193(1):55-65. PubMed ID: 11169516
    [Abstract] [Full Text] [Related]

  • 12. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
    Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM.
    Cancer Res; 2000 Mar 01; 60(5):1177-82. PubMed ID: 10728669
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ, Diao LM, Chen DJ, Li HG, Liu X, Zou ZY, Li BY, Wang M, Liu MQ.
    Ai Zheng; 2003 Jun 01; 22(6):571-4. PubMed ID: 12948402
    [Abstract] [Full Text] [Related]

  • 16. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 17. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC.
    Cancer Res; 2000 Feb 15; 60(4):1049-53. PubMed ID: 10706123
    [Abstract] [Full Text] [Related]

  • 18. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
    Tzao C, Tsai HY, Chen JT, Chen CY, Wang YC.
    Eur J Cancer; 2004 Sep 15; 40(14):2175-83. PubMed ID: 15341994
    [Abstract] [Full Text] [Related]

  • 19. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R, Todd NW, Qiu Q, Fan T, Zhao RY, Rodgers WH, Fang HB, Katz RL, Stass SA, Jiang F.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [Abstract] [Full Text] [Related]

  • 20. The FHIT gene at 3p14.2 is abnormal in breast carcinomas.
    Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM.
    Cancer Res; 1996 Jul 15; 56(14):3173-9. PubMed ID: 8764101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.